BioSpace News Archive

Dr. Dipnarine Maharaj was honored to be invited to present the keynote presentation at this year’s SEMAL Congress.

BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced positive 12 month data for the roll-in cohort of its pivotal CardiAMP™ Heart Failure Trial studying the investigational CardiAMP Cell Therapy System in adult patients experiencing heart failure following a heart attack

Winners of the Frank Awards were announced at The Cannata Report’s 33rd Annual Awards & Charities Dinner at The Madison Hotel in Morristown, N.J. on Thursday, November 8.

Medical Alley’s third quarter ended with new industry records and new milestones set across the board. 27 Medical Alley-based companies raised $176,089,457 in Q3, the second-best Q3 in the last five years.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced David Eidelberg, MD, professor and head of the Feinstein Institute for Medical Research’s Center for Neurosciences and professor of Molecular Medicine and Neurology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, as the recipient of the fourth annual Bachmann-Strauss Prize for Excellence in Dystonia Research.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) awarded the 2018 Robert A. Pritzker Prize for Leadership in Parkinson’s Research to Virginia Man-Yee Lee, PhD, John H. Ware 3rd Endowed Professor in Alzheimer’s Research in the Perelman School of Medicine at the University of Pennsylvania.

Philadelphia-based National Disease Research Interchange (NDRI) announces that it has elected to its Board of Directors David M. Albert J.D., Director of Strategy, Emerging Business & Venture Capital Group of Cozen O’Connor.

People who learn Hands-Only Cardiopulmonary Resuscitation (Hands-Only CPR) using a five-minute, kiosk-based program performed CPR as well as those who attended a 30-minute, facilitator-led training session, according to new research by the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives, published today in Annals of Emergency Medicine.

The Center for Biosimilars®, an online resource for emerging therapies that focuses on improving patient outcomes, will present its latest Peer Exchange titled, “Biosimilars Stakeholders Summit: Best Practices for Biosimilars Education and Promotion” on Thursday, Dec. 13, at 12 p.m., 3 p.m., and 6 p.m. EST.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced enrollment of the first U.S. patient in the Stellarex ILLUMENATE Below-the-Knee (BTK) Investigational Device Exemption (IDE) study, led by principal investigators Dr. Bill Gray and Dr. Mahmood K. Razavi.